The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 226-230

  Whitworth, Jenny M ^a   Londoño Joshi, Angelina I ^b   Sellers, Jeffrey C ^c   Oliver, Patsy J ^c   Muccio, Donald D ^a   Atigadda, Venkatram R ^a   Straughn Jr , J Michael ^a   Buchsbaum, Donald J ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

Ovarian cancer; Retinoid; Stem cell

Indexed keywords

9CUAB124; 9CUAB130; 9CUAB30; CARBOPLATIN; CELL MARKER; PCUAB130; PLATINUM; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; DRUG SCREENING; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; RETINOIDS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84858332297     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.12.425     Document Type: Article

References (29)

1. American Cancer Society Cancer facts and figures 2009
2. K.D. Steffensen, A.B. Alvero, Y. Yang, M. Waldstrom, P. Hui, and J.C. Holmberg Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer J Oncol 2011 2011 620523
3. D. Zhang, W.F. Holmes, S. Wu, D.R. Soprano, and K.J. Soprano Retinoids and ovarian cancer J Cell Physiol 185 2000 1 20
4. M.B. Sporn, and A.B. Roberts Role of retinoids in differentiation and carcinogenesis Cancer Res 43 1983 3034 3040 (Pubitemid 13061542)
5. G. De Palo, L. Mariani, T. Camerini, E. Marubini, F. Formelli, and B. Pasini Effect of fenretinide on ovarian carcinoma occurrence Gynecol Oncol 86 2002 24 27 (Pubitemid 34757046)
6. F. Formelli, and L. Cleris Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity Cancer Res 53 1993 5374 5376 (Pubitemid 23342152)
7. S. Aebi, R. Kroning, B. Cenni, A. Sharma, D. Fink, and G. Los All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells Clin Cancer Res 3 1997 2033 2038 (Pubitemid 27505130)
8. M.J. Caliaro, P. Vitaux, C. Lafon, I. Lochon, A. Nehme, and A. Valette Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines Br J Cancer 75 1997 333 340 (Pubitemid 27051046)
9. W.F. Holmes, D.R. Soprano, and K.J. Soprano Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line J Biol Chem 277 2002 45408 45419 (Pubitemid 36159149)
10. W.F. Holmes, D.R. Soprano, and K.J. Soprano Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR J Cell Biochem 89 2003 262 278 (Pubitemid 36547261)
11. W.F. Holmes, D.R. Soprano, and K.J. Soprano Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway Oncogene 22 2003 6377 6386 (Pubitemid 37281686)
12. M. Cuello, A.O. Coats, I. Darko, S.A. Ettenberg, G.J. Gardner, and M.M. Nau N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines Cell Death Differ 11 2004 527 541 (Pubitemid 38660138)
13. K.M. Moxley, S. Chengedza, and D.M. Benbrook Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: the search for sensitizing agents Gynecol Oncol 115 2009 438 442
14. C. Ginestier, J. Wicinski, N. Cervera, F. Monville, P. Finetti, and F. Bertucci Retinoid signaling regulates breast cancer stem cell differentiation Cell Cycle 8 2009 3297 3302
15. W.K. Love, J.T. Deangelis, J.B. Berletch, S.M. Phipps, L.G. Andrews, and W.J. Brouillette The novel retinoid, 9cUAB30, inhibits telomerase and induces apoptosis in HL60 cells Transl Oncol 1 2008 148 152
16. V.R. Atigadda, K.K. Vines, C.J. Grubbs, D.L. Hill, S.L. Beenken, and K.I. Bland Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8- (3′,4′-dihydro-1′(2′H)-naphthalen-1′-ylidene)-3, 7-dimethyl-2,4,6-octatrienoic acid (9cUAB30) J Med Chem 46 2003 3766 3769 (Pubitemid 36988662)
17. B.M. Boman, and M.S. Wicha Cancer stem cells: a step toward the cure J Clin Oncol 26 2008 2795 2799
18. S. Rizzo, J.M. Hersey, P. Mellor, W. Dai, A. Santos-Silva, and D. Liber Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2 Mol Cancer Ther 10 2011 325 335
19. R. Supino, M. Crosti, M. Clerici, A. Warlters, L. Cleris, and F. Zunino Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression Int J Cancer 65 1996 491 497 (Pubitemid 26084403)
20. N. Suzuki, D. Aoki, S. Oie, M. Horiuchi, Y. Hasegawa, and S. Ezawa A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma Gynecol Oncol 94 2004 643 649 (Pubitemid 39194455)
21. G.J. Rustin, T.G. Quinnell, J. Johnson, H. Clarke, A.E. Nelstrop, and W. Bollag Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer Br J Cancer 74 1996 1479 1481 (Pubitemid 26370743)
22. N. Colombo, F. Formelli, M.G. Cantu, G. Parma, M. Gasco, and A. Argusti A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer Cancer Epidemiol Biomarkers Prev 15 2006 1914 1919 (Pubitemid 44664268)
23. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567 (Pubitemid 350056407)
24. S. Ma, K.W. Chan, T.K. Lee, K.H. Tang, J.Y. Wo, and B.J. Zheng Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations Mol Cancer Res 6 2008 1146 1153
25. E.H. Huang, M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, and H. Appelman Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res 69 2009 3382 3389
26. G. Duester, F.A. Mic, and A. Molotkov Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid Chem Biol Interact 143-144 2003 201 210 (Pubitemid 36246442)
27. K. Penumatsa, S.L. Edassery, A. Barua, M.J. Bradaric, and J.L. Luborsky Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors J Ovarian Res 3 2010 28
28. I.A. Silva, S. Bai, K. McLean, K. Yang, K.A. Griffith, and T. Dafydd Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res 71 2011 3991 4001
29. C.N. Landen Jr., B. Goodman, A.A. Katre, A.D. Steg, A.M. Nick, and R.L. Stone Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol Cancer Ther 9 2010 3186 3199